The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss

被引:0
|
作者
Essam, Reham [1 ]
Selim, Heba [1 ]
Ehab, Rana [1 ]
机构
[1] Zagazig Univ, Dept Dermatol Venereol & Androl, Fac Med, Zagazig, Egypt
来源
关键词
dutasteride; female pattern hair loss; microneedling; minoxidil; trichoscopy;
D O I
10.4103/jewd.jewd_35_23
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Female pattern hair loss (FPHL) is a disease characterized by progressive hair thinning. Topical minoxidil is an FDA-approved drug for the treatment of androgenetic alopecia. Dutasteride (a 5 alpha-reductase inhibitor) can also be used in a topical form to reduce its systemic side effects. Both agents can be used as mesotherapy after microneedling of the scalp to enhance their potency in the treatment of FPHL. Objective To compare the use of combined minoxidil and dutasteride versus dutasteride alone when applied topically after microneedling of the scalp in the treatment of FPHL. Patients and methods This study included 40 female patients with FPHL. Patients were divided into two groups: one group was treated with combined minoxidil 0.1% and dutasteride 0.01% with microneedling, and the other group received dutasteride 0.01% alone with microneedling. Trichoscopic evaluation was done. Results In a group A, who were treated with combined minoxidil and dutasteride, 4 patients (20%) had excellent improvement, 10 patients (50%) had a good response, 5 patients (25%) had a moderate response, and only 1 patient (5%) had no response, while in a group B, who treated with dutasteride, 1 patient (5%) had excellent improvement, 4 patients (20%) had a good response, 10 patients (50%) had a moderate response, and 5patients(25%) had no response, with a significant difference between both groups (P=0.033. There were the nonsignificant difference between both groups regarding trichoscopic findings before treatment, but after treatment, there was a significant difference between both groups concerning the mean percentage of the follicular unit with one hair and the number of patients who had vellus hairs in the dermoscopic field. Conclusion The combination of minoxidil 0.1% and dutasteride 0.01% after microneedling of the scalp was significantly more effective than dutasteride alone with microneedling for the treatment of FPHL.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [41] Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia
    McMichael, Amy
    Pham, Hanh
    von Grote, Erika
    Meckfessel, Matthew H.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (04) : 398 - 404
  • [42] Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss
    Correa, Adriana C.
    Machado, Carla J.
    Carneiro, Sueli C. S.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [43] Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial
    Ibrahim, Ibrahim M.
    Hasan, Mohamed S.
    Elsabaa, Khaled I.
    Elsaie, Mohamed L.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (09) : 2867 - 2873
  • [44] Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis
    Gupta, Aditya K.
    Wang, Tong
    Bamimore, Mary A.
    Ravi, Shruthi Polla
    Talukder, Mesbah
    [J]. SKIN APPENDAGE DISORDERS, 2023, 9 (06) : 397 - 406
  • [45] Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients
    Moussa, Anthony
    Kazmi, Ahmed
    Bokhari, Laita
    Sinclair, Rodney D.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 488 - 490
  • [46] Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women
    Rodrigues-Barata, Rita
    Moreno-Arrones, Oscar M.
    Saceda-Corralo, David
    Jimenez-Cauhe, Juan
    Ortega-Quijano, Daniel
    Fernandez-Nieto, Diego
    Jaen-Olasolo, Pedro
    Vano-Galvan, Sergio
    [J]. SKIN APPENDAGE DISORDERS, 2020, 6 (03): : 175 - 176
  • [47] Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
    Yazdabadi, A.
    Sinclair, R.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 7 - 8
  • [48] Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss
    Hu, Lifang
    Dai, YeQin
    Zhang, Hongyan
    Wu, Yi
    Wang, Tao
    Song, Xiuzu
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (04)
  • [49] Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
    Yazdabadi, Anosha
    Sinclair, Rod
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 (02) : 132 - 134
  • [50] Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss
    Rathnayake, Deepani
    Sinclair, Rodney
    [J]. DERMATOLOGIC CLINICS, 2010, 28 (03) : 611 - +